Bimodal perfluorocarbon nanoemulsions for nasopharyngeal carcinoma targeting

Molecular Imaging and Biology

Volumn 15, Issue 4, 2013, Pages 401-410

  Bae, Pan Kee ^a   Jung, Juyeon ^a   Lim, Su Jin ^b   Kim, Daehong ^c   Kim, Seok Ki ^c   Chung, Bong Hyun ^a  

^a Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^b Korea Research Institute of Chemical Technology   (South Korea)

^c National Cancer Center   (South Korea)

Author keywords

19F MR; Bimodal nanoemulsion; Cancer; Cancer specific imaging; MRI; Optical imaging; Perfluorocarbon

Indexed keywords

FLUOROCARBON; FOLATE RECEPTOR; FOLIC ACID; PHOSPHOLIPID; RHODAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; CANCER CELL; CELL VIABILITY; CONTROLLED STUDY; DRUG CYTOTOXICITY; FLUORESCENCE ACTIVATED CELL SORTING; FLUORESCENCE IMAGING; HUMAN; HUMAN CELL; IMAGING SYSTEM; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NANOEMULSION; NANOPROBE; NASOPHARYNX CARCINOMA; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; TUMOR XENOGRAFT;

ANIMALS; CELL DEATH; CELL LINE, TUMOR; EMULSIONS; FLOW CYTOMETRY; FLUOROCARBONS; FOLATE RECEPTORS, GPI-ANCHORED; FOLIC ACID; HUMANS; MAGNETIC RESONANCE IMAGING; MICE; MICROSCOPY, FLUORESCENCE; NANOPARTICLES; NASOPHARYNGEAL NEOPLASMS; OPTICAL PHENOMENA; RHODAMINES;

EID: 84880326326     PISSN: 15361632     EISSN: 18602002     Source Type: Journal    
DOI: 10.1007/s11307-013-0622-2     Document Type: Article

References (41)

1. Park JH, Von Maltzahn G, Ruoslahti E et al (2008) Micellar hybrid nanoparticles for simultaneous magnetofluorescent imaging and drug delivery. Angew Chem Int Ed 47:7284-7288
2. Yang H, Santra S, Walter GA, Holloway PH (2006) Gd(III)-functionalized fluorescent quantum dots as multimodal imaging probes. Adv Mater 18:2890-2894
3. Beaune G, Dubertret B, Clement O et al (2007) Giant vesicles containing magnetic nanoparticles and quantum dots: feasibility and tracking by fiber confocal fluorescence microscopy. Angew Chem Int Ed 46:5421-5424
4. Wang S, Jarrett BR, Kauzlarich SM, Louie AY (2007) Core/shell quantum dots with high relaxivity and photoluminescence for multimodality imaging. J Am Chem Soc 129:3848-3856
5. Lim YT, Noh YW, Cho JH et al (2009) Multiplexed imaging of therapeutic cells with multispectrally encoded magnetofluorescent nanocomposite emulsions. J Am Chem Soc 131:17145-17154
6. Lanza GM, Winter PM, Neubauer AM et al (2005) 1H/19F magnetic resonance molecular imaging with perfluorocarbon nanoparticles. Curr Top Dev Bio 70:57-76
7. Ahrens ET, Flores R, Xu H, Morel PA (2005) In vivo imaging platform for tracking immunotherapeutic cells. Nat Biotechnol 23:983-987
8. 1H MRI detection of amyloid beta plaques in vivo. Nat Neurosci 8:527-533
9. Janjic JM, Ahrens ET (2009) Fluorine-containing nanoemulsions for MRI cell tracking. Wiley Interdiscip Rev Nanomed 1:492-501
10. Tran TD, Caruthers SD, Hughes M et al (2007) Clinical applications of perfluorocarbon nanoparticles for molecular imaging and targeted therapeutics. Int J Nanomedicine 2:515-526
11. Rapoport N, Gao Z, Kennedy A (2007) Multifunctional nanoparticles for combining ultrasonic tumor imaging and targeted chemotherapy. J Natl Canc Inst 99:1095-1106
12. Croce MA, Fabian TC, Patton JH et al (1998) Partial liquid ventilation decreases the inflammatory response in the alveolar environment of trauma patients. J Trauma 45:273-282
13. Brown JJ, Duncan JR, Heiken JP et al (1991) Perfluoroctylbromide as a gastrointestinal contrast agent for MR imaging: use with and without glucagon. Radiology 181:455-460
14. McGoron AJ, Pratt R, Zhang J et al (1994) Perfluorocarbon distribution to liver, lung and spleen of emulsions of perfluorotributylamine (FTBA) in pigs and rats and perfluorooctyl bromide (PFOB) in rats and dogs by 19F NMR spectroscopy. Artif Cells Blood Substit Immobil Biotechnol 22:1243-1250
15. Keipert PE, Otto S, Flaim SF et al (1994) Influence of perflubron emulsion particle size on blood half-life and febrile response in rats. Artif Cells Blood Substit Immobil Biotechnol 22:1169-1174
16. Antony AC (1992) The biological chemistry of folate receptors. Blood 79:2807-2820
17. Kamen BA, Smith AK (2004) A review of folate receptor alpha cycling and 5-methyltetrahydrofolate accumulation with an emphasis on cell models in vitro. Adv Drug Deliv Rev 56:1085-1097
18. Reddy JA, Allagadda VM, Leamon CP (2005) Targeting therapeutic and imaging agents to folate receptor positive tumors. Curr Pharm Biotechnol 6:131-150
19. Wang ZJ, Boddington S, Wendland M et al (2008) MR imaging of ovarian tumors using folate-receptor-targeted contrast agents. Pediatr Radiol 38:529-537
20. Ke CY, Mathias CJ, Green MA (2004) Folate-receptor-targeted radionuclide imaging agents. Adv Drug Deliv Rev 56:1143-1160
21. Hilgenbrink AR, Low PS (2005) Folate receptor-mediated drug targeting: from therapeutics to diagnostics. J Pharm Sci 94:2135-2146
22. Weitman SD, Lark RH, Coney LR et al (1992) Distribution of the folate receptor GP38 in normal and malignant cell lines and tissues. Cancer Res 52:3396-3401
23. Ross JF, Chaudhuri PK, Ratnam M (1994) Differential regulation of folate receptor isoforms in normal and malignant tissues in vivo and in established cell lines. Physiologic and clinical implications. Cancer 73:2432-2443
24. Weitman SD, Weinberg AG, Coney LR et al (1992) Cellular localization of the folate receptor: potential role in drug toxicity and folate homeostasis. Cancer Res 52:6708-6711
25. Franklin WA, Waintrub M, Edwards D et al (1994) New anti-lung-cancer antibody cluster 12 reacts with human folate receptors present on adenocarcinoma. Int J Canc Suppl 8:89-95
26. Salazar MD, Ratnam M (2007) The folate receptor: what does it promise in tissue-targeted therapeutics? Cancer Metastasis Rev 26:141-152
27. Sega EI, Low PS (2008) Tumor detection using folate receptor-targeted imaging agents. Cancer Metastasis Rev 27:655-664
28. Mathias CJ, Wang S, Waters DJ et al (1998) Indium-111-DTPA-folate as a potential folate-receptor-targeted radiopharmaceutical. J Nucl Med 39:1579-1585
29. Okarvi SM, Jammaz IA (2006) Preparation and in vitro and in vivo evaluation of technetium-99m-labeled folate and methotrexate conjugates as tumor imaging agents. Cancer Biother Radiopharm 21:49-60
30. Choi H, Choi SR, Zhou R et al (2004) Iron oxide nanoparticles as magnetic resonance contrast agent for tumor imaging via folate receptor-targeted delivery. Acad Radiol 11:996-1004
31. Waters EA, Chen J, Allen JS et al (2008) Detection and quantification of angiogenesis in experimental valve disease with integrin-targeted nanoparticles and 19-fluorine MRI/MRS. J Cardiovasc Magn Reson 10:43
32. Bharali DJ, Lucey DW, Jayakumar H et al (2005) Folate-receptor-mediated delivery of InP quantum dots for bioimaging using confocal and two-photon microscopy. J Am Chem Soc 127:11364-11371
33. Milstein AB, Kennedy MD, Low PS et al (2005) Statistical approach for detection and localization of a fluorescing mouse tumor in intralipid. Appl Opt 44:2300-2310
34. Kamaly N, Kalber T, Thanou M, Bell JD, Miller AD (2009) Folate receptor targeted bimodal liposomes for tumor magnetic resonance imaging. Bioconjug Chem 20:648-655
35. Flögel U, Ding Z, Hardung H et al (2008) In vivo monitoring of inflammation after cardiac and cerebral ischemia by fluorine magnetic resonance imaging. Circulation 118:140-148
36. Partlow KC, Chen J, Brant JA et al (2007) 19F magnetic resonance imaging for stem/progenitor cell tracking with multiple unique perfluorocarbon nanobeacons. FASEB J 21:1647-1654
37. Barnett BP, Ruiz-Cabello J, Hota P et al (2011) Use of perfluorocarbon nanoparticles for non-invasive multimodal cell tracking of human pancreatic islets. Contrast Media Mol Imaging 6:251-259
38. Díaz-López R, Tsapis N, Libong D et al (2009) Phospholipid decoration of microcapsules containing perfluorooctyl bromide used as ultrasound contrast agents. Biomaterials 30:1462-1472
39. Lee RJ, Low PS (1994) Delivery of liposomes into cultured KB cells via folate receptor-mediated endocytosis. J Biol Chem 269:3198-3204
40. Storm G, Belliot S, Daemen T, Lasic D (1995) Surface modification of nanoparticles to oppose uptake by the mononuclear phagocyte system. Adv Drug Deliv Rev 17:31-48
41. Longstaff E (1988) Carcinogenic and mutagenic potential of several fluorocarbons. Ann N Y Acad Sci 534:283-298